查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1607755

尼古丁口腔溶解性薄膜的全球市场:强度·给药途径·年龄层·销售管道·不同地区的预测 (～2032年)

Global Nicotine Oral Dissolvable Thin Films Market Research Report Information by Strength, by Route of Administration, and by Age Group, by Sales Channel, and by Region Forecast till 2032
出版日期: | 出版商: Market Research Future | 英文 146 Pages | 订单完成后即时交付

价格

全球尼古丁口溶薄膜市场规模预计将从2023年的1亿美元成长到2024年的1.1亿美元，预测期内复合年增长率为3.86%，预计2032年将达到1亿美元。 5000 万美元。

反吸烟力度不断加大，推动了尼古丁口溶片的巨大需求，并以多种方式加速了市场成长。透过公共卫生运动和吸烟与健康办公室 (OSH) 等政府举措，积极鼓励人们戒烟并减少尼古丁摄取。旨在减少烟草使用的计划透过提供工具和资源来实施有效的戒烟策略来支持这些努力。

此外，口腔膜片（OTF）技术的优势是推动全球尼古丁口腔可溶膜片市场的关键因素。 OTF 在口中快速溶解，无需水，使其成为一种简单且便携的尼古丁输送方式。用户可以随时随地谨慎使用。

区域洞察

北美市场预计将从 2023 年的 3,120 万美元开始成长，预测期内复合年增长率为 3.86%。由于人们对戒烟辅助剂的认识不断提高以及吸烟相关疾病盛行率的上升，北美尼古丁口服可溶薄膜市场正在迅速扩大。

欧洲尼古丁口腔溶解薄膜市场预计将从 2023 年的 4,448 万美元开始成长，预测期内复合年增长率为 3.46%。由于尼古丁口溶膜的日益普及以及行业参与者的存在，欧洲尼古丁口溶膜市场预计在未来几年将显着成长。

预计亚太地区尼古丁口腔溶解薄膜市场在预测期内将以 4.77% 的复合年增长率成长，2023 年为 2,074 万美元。由于中国、韩国、印度和日本等国家健康意识的提高、城市化和高吸烟率，该区域市场正在迅速扩大。

本报告提供全球尼古丁口腔溶解性薄膜的市场调查，彙整市场定义和概要，市场成长的各种影响因素分析，市场规模的转变·预测，各种区分·地区/各主要国家的明细，竞争环境，主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场动态

  • 促进因素
    • 加强戒烟与戒烟工作
    • 口腔膜剂的优点
  • 阻碍因素
    • 严格的监理政策
    • 尼古丁替代疗法的存在
    • 尼古丁口腔膜剂产品的专利保护
  • 机会
    • 开始建造并启动口腔膜生产
    • 与尼古丁口腔膜相关的创新

第5章 市场要素分析

  • 价值链分析
  • 波特五力分析
  • COVID-19 对全球尼古丁口服溶胶薄膜市场的影响
  • 尼古丁口溶薄膜包装的质性讯息
  • 有关尼古丁口腔溶解薄膜最终用户的定性讯息
  • 按地区划分的价格分析

第6章 全球尼古丁口腔溶解性薄膜市场:强度

  • 概要
  • 1MG
  • 2MG
  • 其他

第7章 全球尼古丁口腔溶解性薄膜市场:各给药途径

  • 概要
  • 舌头
  • 脸颊

第8章 全球尼古丁口腔溶解性薄膜市场:各年龄层)

  • 概要
  • 成人
  • 青年人

第9章 全球尼古丁口腔溶解性薄膜市场:各销售管道

  • 概要
  • 线上
  • 离线

第10章 全球尼古丁口腔溶解性薄膜市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 其他
  • 其他地区
    • 南美
    • 中东·非洲

第11章 竞争情形

  • 市场占有率分析
  • 竞争仪表板
  • 上市公司的股票概要
  • 比较分析:主要企业的财务
  • 主要的展开·成长策略

第12章 企业简介

  • NICOCCINO HOLDING AB
  • NISSHA CO., LTD.
  • ADHEXPHARMA
  • ARX, LLC
  • ZIM LABORATORIES LIMITED
  • LTS LOHMANN THERAPIE-SYSTEME AG
  • NAL PHARMA
  • INVENTZ
  • RENEJIX PHARMA SOLUTIONS
  • DK LIVKON PVT. LTD

第13章 资料的引用

Product Code: MRFR/HC/26893-CR

Global Nicotine Oral Dissolvable Thin Films Market Research Report Information by Strength (1mg, 2mg, and Others), by Route of Administration (Tongue and Buccal), and by Age Group (Adults and Adolescents), by Sales Channel (Online and Offline), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032

Market Overview

The market for Nicotine Oral Dissolvable Thin Films was estimated to be worth USD 0.10 billion by 2023. The Nicotine Oral Dissolvable Thin Films Market is expected to increase from USD 0.11 billion in 2024 to USD 0.15 billion by 2032, with a compound yearly growth rate (CAGR) of 3.86% over the forecast period (2024-2032).

Significant demand for nicotine oral dissolvable thin films is being driven by growing efforts to quit smoking, which is accelerating market growth in a variety of ways. People are actively encouraged to quit smoking or reduce their nicotine consumption through public health campaigns and government initiatives, such as those run by the Office on Smoking and Health (OSH). Programs targeted at lowering tobacco use help in these efforts by providing tools and resources for implementing effective stop strategies.

Furthermore, the advantages of oral thin film (OTF) technology are important factors propelling the global nicotine oral dissolvable thin film market. Here are a few significant advantages that contribute to market expansion. OTFs dissolve quickly in the mouth and do not require water, making them a simple and portable form of nicotine delivery. Users can use them discreetly at any time and from any place.

Market Segment insights

The Nicotine Oral Dissolvable Thin Films Market is divided into three segments based on strength: 1mg, 2mg, and Others.

The Market has been divided into two sections based on the way of administration.

The Nicotine Oral Dissolvable Thin Films Market is divided into two age groups: adults and adolescents.

The market has been divided into two segments based on the sales channel: online and offline.

Regional insights

The North America Nicotine Oral Dissolvable Thin Films Market was worth USD 31.20 million in 2023, and it is expected to increase at a CAGR of 3.86% over the forecast period. North America is further divided into the United States and Canada. The North American nicotine oral dissolvable thin films market is expanding rapidly, driven by increased awareness of smoking cessation aids and the rising prevalence of smoking-related health conditions.

The Europe Nicotine Oral Dissolvable Thin Films Market was worth USD 44.48 million in 2023, and it is expected to increase at a CAGR of 3.46% over the forecast period. The European nicotine oral dissolvable thin films market is expected to increase significantly in the coming years, owing to the increasing popularity of nicotine oral dissolvable thin films and the existence of industry players.

The Asia-Pacific Nicotine Oral Dissolvable Thin Films Market was worth USD 20.74 million in 2023, and it is expected to increase at a CAGR of 4.77% over the forecast period. The Asia-Pacific nicotine oral dissolvable thin films market is expanding rapidly due to rising health awareness, urbanization, and high smoking rates in countries such as China, South Korea, India, and Japan.

Major Players

Nicoccino Holding AB (Japan), AdhexPharma (France), ARx, LLC (US), ZIM Laboratories Limited (India), LTS Lohmann Therapie-Systeme AG (Germany), NAL Pharma (China), INVENTZ Lifesciences (India), Renejix Pharma Solutions (US), and DK Livkon Healthcare Pvt. Ltd. (India) are among the market's key players.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TYPE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING SMOKING AND TOBACCO CESSATION EFFORTS
    • 4.2.2 ADVANTAGE OF ORAL THIN FILM DRIVES THE MARKET GROWTH
  • 4.3 RESTRAINTS
    • 4.3.1 STRINGENT REGULATORY POLICIES
    • 4.3.2 PRESENCE OF NICOTINE REPLACEMENT THERAPIES
    • 4.3.3 PATENT PROTECTION OF NICOTINE ORAL THIN FILM PRODUCTS
  • 4.4 OPPORTUNITY
    • 4.4.1 INITIATION TO BUILD AND LAUNCH ORAL THIN FILM MANUFACTURING
    • 4.4.2 INNOVATION ASSOCIATED WITH NICOTINE ORAL THIN FILM

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION & SALES
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET
  • 5.4 QUALITATIVE INFORMATION ON PACKAGING OF NICOTINE ORAL DISSOLVABLE THIN FILMS
    • 5.4.1 PACKAGING MATERIALS
      • 5.4.1.1 FOIL, PAPER, OR PLASTIC POUCHES
      • 5.4.1.2 SINGLE POUCH AND ALUMINUM POUCH
      • 5.4.1.3 BLISTER CARD WITH MULTIPLE UNITS
      • 5.4.1.4 BARRIER FILMS
    • 5.4.2 LABELING AND INFORMATION FOR NICOTINE ORAL DISSOLVABLE THIN FILMS
      • 5.4.2.1 REGULATORY COMPLIANCE
      • 5.4.2.2 NICOTINE DOSAGE
      • 5.4.2.3 WARNINGS AND PRECAUTIONS
      • 5.4.2.4 EXPIRATION DATES
  • 5.5 QUALITATIVE INFORMATION ON END USE OF NICOTINE ORAL DISSOLVABLE THIN FILMS
    • 5.5.1 CHALLENGES IN FORMULATION, STABILITY, AND MANUFACTURING OF ORAL THIN FILM (OTF)
    • 5.5.2 STRINGENT REGULATORY POLICIES FOR THE GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILM MARKET
  • 5.6 QUALITATIVE INFORMATION ON END USE OF NICOTINE ORAL DISSOLVABLE THIN FILMS
    • 5.6.1 SMOKERS & EX-SMOKERS
    • 5.6.2 CONVENIENCE AND DISCREET USE
  • 5.7 PRICING ANALYSIS, BY REGION 2023 (USD)

6 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH

  • 6.1 OVERVIEW
  • 6.2 1MG
  • 6.3 2MG
  • 6.4 OTHERS

7 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION

  • 7.1 OVERVIEW
  • 7.2 TONGUE
  • 7.3 BUCCAL

8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP

  • 8.1 OVERVIEW
  • 8.2 ADULTS
  • 8.3 ADOLESCENTS

9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL

  • 9.1 OVERVIEW
  • 9.2 ONLINE
  • 9.3 OFFLINE

10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 US
    • 10.2.2 CANADA
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 FRANCE
    • 10.3.3 UK
    • 10.3.4 ITALY
    • 10.3.5 SPAIN
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    • 10.4.1 CHINA
    • 10.4.2 INDIA
    • 10.4.3 JAPAN
    • 10.4.4 SOUTH KOREA
    • 10.4.5 AUSTRALIA
    • 10.4.6 REST OF ASIA-PACIFIC
  • 10.5 REST OF THE WORLD
    • 10.5.1 LATIN AMERICA
    • 10.5.2 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 MARKET SHARE ANALYSIS,
  • 11.3 COMPETITOR DASHBOARD
  • 11.4 PUBLIC PLAYERS STOCK SUMMARY
  • 11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 11.6.1 AGREEMENT
    • 11.6.2 EXPANSION
    • 11.6.3 PRODUCT APPROVAL
    • 11.6.4 PRODUCT RECOGNITION

12 COMPANY PROFILES

  • 12.1 NICOCCINO HOLDING AB
    • 12.1.1 COMPANY OVERVIEW
    • 12.1.2 FINANCIAL OVERVIEW
    • 12.1.3 PRODUCTS OFFERED
    • 12.1.4 ADDITIONAL INFORMATION
    • 12.1.5 KEY DEVELOPMENTS
    • 12.1.6 SWOT ANALYSIS
    • 12.1.7 KEY STRATEGIES
  • 12.2 NISSHA CO., LTD.
    • 12.2.1 COMPANY OVERVIEW
    • 12.2.2 FINANCIAL OVERVIEW
    • 12.2.3 PRODUCTS OFFERED
    • 12.2.4 ADDITIONAL INFORMATION
    • 12.2.5 KEY DEVELOPMENTS
    • 12.2.6 SWOT ANALYSIS
    • 12.2.7 KEY STRATEGIES
  • 12.3 ADHEXPHARMA
    • 12.3.1 COMPANY OVERVIEW
    • 12.3.2 FINANCIAL OVERVIEW
    • 12.3.3 PRODUCT OFFERED
    • 12.3.4 ADDITIONAL INFORMATION
    • 12.3.5 KEY DEVELOPMENTS
    • 12.3.6 KEY STRATEGIES
  • 12.4 ARX, LLC
    • 12.4.1 COMPANY OVERVIEW
    • 12.4.2 FINANCIAL OVERVIEW
    • 12.4.3 PRODUCTS OFFERED
    • 12.4.4 ADDITIONAL INFORMATION
    • 12.4.5 KEY DEVELOPMENTS
    • 12.4.6 KEY STRATEGIES
  • 12.5 ZIM LABORATORIES LIMITED
    • 12.5.1 COMPANY OVERVIEW
    • 12.5.2 FINANCIAL OVERVIEW
    • 12.5.3 PRODUCTS OFFERED
    • 12.5.4 ADDITIONAL INFORMATION
    • 12.5.5 KEY DEVELOPMENTS
    • 12.5.6 SWOT ANALYSIS
    • 12.5.7 KEY STRATEGIES
  • 12.6 LTS LOHMANN THERAPIE-SYSTEME AG
    • 12.6.1 COMPANY OVERVIEW
    • 12.6.2 FINANCIAL OVERVIEW
    • 12.6.3 PRODUCTS OFFERED
    • 12.6.4 ADDITIONAL INFORMATION
    • 12.6.5 KEY DEVELOPMENTS
    • 12.6.6 SWOT ANALYSIS
    • 12.6.7 KEY STRATEGIES
  • 12.7 NAL PHARMA
    • 12.7.1 COMPANY OVERVIEW
    • 12.7.2 FINANCIAL OVERVIEW
    • 12.7.3 PRODUCTS OFFERED
    • 12.7.4 ADDITIONAL INFORMATION
    • 12.7.5 KEY DEVELOPMENTS
    • 12.7.6 KEY STRATEGIES
  • 12.8 INVENTZ
    • 12.8.1 COMPANY OVERVIEW
    • 12.8.2 FINANCIAL OVERVIEW
    • 12.8.3 PRODUCTS OFFERED
    • 12.8.4 ADDITIONAL INFORMATION
    • 12.8.5 KEY DEVELOPMENTS
    • 12.8.6 SWOT ANALYSIS
    • 12.8.7 KEY STRATEGIES
  • 12.9 RENEJIX PHARMA SOLUTIONS
    • 12.9.1 COMPANY OVERVIEW
    • 12.9.2 FINANCIAL OVERVIEW
    • 12.9.3 SERVICES OFFERED
    • 12.9.4 ADDITIONAL INFORMATION
    • 12.9.5 KEY DEVELOPMENTS
    • 12.9.6 KEY STRATEGIES
  • 12.10 DK LIVKON PVT. LTD
    • 12.10.1 COMPANY OVERVIEW
    • 12.10.2 FINANCIAL OVERVIEW
    • 12.10.3 SERVICES OFFERED
    • 12.10.4 ADDITIONAL INFORMATION
    • 12.10.5 KEY DEVELOPMENTS
    • 12.10.6 KEY STRATEGIES

13 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 ADVANTAGE OF ORAL THIN FILM
  • TABLE 3 PATENT PROTECTION OF NICOTINE ORAL THIN FILM PRODUCTS
  • TABLE 4 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR 1MG, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR 2MG, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR TONGUE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR BUCCAL, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ADULTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ADOLESCENTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ONLINE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR OFFLINE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 19 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 20 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 21 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 22 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 23 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 24 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 25 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 26 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 27 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 28 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 29 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 30 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 31 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 1 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 2 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 3 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 4 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 5 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 6 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 7 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 8 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 9 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 10 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 11 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 12 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 13 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 14 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 15 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 16 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 17 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 18 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 19 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 20 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 21 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 22 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 23 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 24 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 25 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 26 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 27 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 28 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 29 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 1 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 2 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 3 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 4 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 5 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 6 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 7 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 8 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 9 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 10 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 11 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 12 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 13 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 14 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 15 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 16 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 17 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 18 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 19 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 20 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 21 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 22 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 23 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 24 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 1 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 2 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 3 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 4 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 5 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 1 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 2 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 3 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 4 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 5 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 6 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 7 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 8 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 9 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019-2032 (USD MILLION)
  • TABLE 10 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019-2032 (USD MILLION)
  • TABLE 11 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019-2032 (USD MILLION)
  • TABLE 12 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019-2032 (USD MILLION)
  • TABLE 13 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 14 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 15 AGREEMEENT
  • TABLE 16 EXPANSION
  • TABLE 17 PRODUCT APPROVAL
  • TABLE 18 PRODUCT RECOGNITION
  • TABLE 19 NICOCCINO HOLDING AB: PRODUCTS OFFERED
  • TABLE 20 NICOCCINO HOLDING AB: ADDITIONAL INFORMATION
  • TABLE 21 NISSHA CO., LTD.: PRODUCTS OFFERED
  • TABLE 22 NISSHA CO., LTD.: ADDITIONAL INFORMATION
  • TABLE 23 ADHEXPHARMA: PRODUCTS OFFERED
  • TABLE 24 ADHEXPHARMA: ADDITIONAL INFORMATION
  • TABLE 25 ARX, LLC: PRODUCTS OFFERED
  • TABLE 26 ARX, LLC: ADDITIONAL INFORMATION
  • TABLE 27 ZIM LABORATORIES LIMITED: PRODUCTS OFFERED
  • TABLE 28 ZIM LABORATORIES LIMITED: ADDITIONAL INFORMATION
  • TABLE 29 ZIM LABORATORIES LIMITED: KEY DEVELOPMENTS
  • TABLE 30 LTS LOHMANN THERAPIE-SYSTEME AG: PRODUCTS OFFERED
  • TABLE 31 LTS LOHMANN THERAPIE-SYSTEME AG: ADDITIONAL INFORMATION
  • TABLE 32 NAL PHARMA: PRODUCTS OFFERED
  • TABLE 33 ADDITIONAL INFORMATION
  • TABLE 34 INVENTZ: PRODUCTS OFFERED
  • TABLE 35 INVENTZ: ADDITIONAL INFORMATION
  • TABLE 36 RENEJIX PHARMA SOLUTIONS: SERVICES OFFERED
  • TABLE 37 RENEJIX PHARMA SOLUTIONS: ADDITIONAL INFORMATION
  • TABLE 38 DK LIVKON PVT. LTD: SERVICES OFFERED
  • TABLE 39 DK LIVKON PVT. LTD: ADDITIONAL INFORMATION

LIST OF FIGURES

  • FIGURE 1 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET: STRUCTURE
  • FIGURE 2 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 VALUE CHAIN ANALYSIS: GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILM MARKET
  • FIGURE 6 MANUFACTURING PROCESS FOR THE NICOTINE ORAL DISSOLVABLE THIN FILM
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET
  • FIGURE 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, STRENGTH SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY STRENGTH,
  • FIGURE 11 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, ROUTE OF ADMINISTRATION SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 12 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2023 & 2032 (USD MILLION)
  • FIGURE 13 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY ROUTE OF ADMINISTRATION,
  • FIGURE 14 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, AGE GROUP SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 15 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2023 & 2032 (USD MILLION)
  • FIGURE 16 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY AGE GROUP,
  • FIGURE 17 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, SALES CHANNEL SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)
  • FIGURE 18 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2023 & 2032 (USD MILLION)
  • FIGURE 19 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY SALES CHANNEL,
  • FIGURE 20 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 21 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION,
  • FIGURE 22 NORTH AMERICA MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 23 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 24 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 25 EUROPE MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 26 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 27 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION,
  • FIGURE 28 ASIA-PACIFIC MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2030 (USD MILLION)
  • FIGURE 29 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 30 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 31 REST OF THE WORLD MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)
  • FIGURE 32 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 33 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION,
  • FIGURE 34 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET PLAYERS: COMPETITIVE ANALYSIS,
  • FIGURE 35 COMPETITOR DASHBOARD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET
  • FIGURE 36 NICOCCINO HOLDING AB: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 37 NICOCCINO HOLDING AB: SWOT ANALYSIS
  • FIGURE 38 NISSHA CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 39 NISSHA CO., LTD.: SWOT ANALYSIS
  • FIGURE 40 ZIM LABORATORIES LIMITED: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 ZIM LABORATORIES LIMITED: SWOT ANALYSIS
  • FIGURE 42 LTS LOHMANN THERAPIE-SYSTEME AG: SWOT ANALYSIS
  • FIGURE 43 INVENTZ: SWOT ANALYSIS